REG News

Latest REG News

• Regeneron Advances ALN-CIDEB Into Phase 3 Liver Disease Study
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
• Daiwa Reaffirms Their Buy Rating on RemeGen Co. Ltd. Class H (9995)
  TipRanks Auto-Generated Intelligence Newsdesk · Nov 5, 2026
• EREGL.TE Shares Face Takasbank Default Buy-In
  TipRanks Turkey Auto-Generated Newsdesk · Nov 4, 2026
• Regeneron and Sanofi Update Long-Term Pediatric Dupixent Study
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 3, 2026
• CMB Converts Polisan Shares to Non-Publicly Traded Status
  TipRanks Turkey Auto-Generated Newsdesk · Nov 3, 2026
• Regeneron (REGN) Receives a Rating Update from a Top Analyst
  TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
• Analysts Conflicted on These Healthcare Names: AbbVie (ABBV), Regeneron (REGN) and Stoke Therapeutics (STOK)
  TipRanks Newsroom · Nov 2, 2026
• Regeneron Earnings Call Highlights Explosive Growth, Deep Pipeline
  TipRanks Auto-Generated Newsdesk · Nov 1, 2026
• UBS Sticks to Its Buy Rating for RemeGen Co. Ltd. Class H (9995)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 31, 2026
• Regeneron Expands Skin Cancer Pipeline With New Cemiplimab Combo Trial
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 30, 2026
• Sanofi and Regeneron Advance Dupixent Coformulation in Key Phase 1 Study
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 29, 2026
• Creactives Group Approves 2026 Accounts and Strengthens Governance
  TipRanks Italy Auto-Generated Newsdesk · Oct 28, 2026
• JCR Eurasia Affirms AAA (tr) Rating for Ereğli Demir ve Çelik with Stable Outlook
  TipRanks Turkey Auto-Generated Newsdesk · Oct 26, 2026
• The Week That Was, The Week Ahead: Macro and Markets, October 25
  Ran Melamed · Oct 25, 2026
• Regis Healthcare Clarifies EPS Metric in AGM Notice Correction
  TipRanks Australian Auto-Generated Newsdesk · Oct 22, 2026
• Capital Markets Board Converts Select Turkish Listed Shares to Non-Publicly Traded Status
  TipRanks Turkey Auto-Generated Newsdesk · Oct 21, 2026
• Regeneron (REGN) Receives a Rating Update from a Top Analyst
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
• Ereğli Demir ve Çelik Converts Block of Shares into Exchange-Traded Stock
  TipRanks Turkey Auto-Generated Newsdesk · Oct 20, 2026
• Ereğli Demir ve Çelik Converts Block of Shares into Exchange-Traded Stock
  TipRanks Turkey Auto-Generated Newsdesk · Oct 20, 2026
• Amprius, Viking, Regeneron, Ionis, Crispr Trending With Analysts
  TipRanks Weekend Auto-Generated Newsdesk · Oct 17, 2026